BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21960171)

  • 1. Association with Helicobacter pylori infection and ghrelin level in hemodialysis patients.
    Sugimoto M; Yasuda H
    Kidney Int; 2011 Oct; 80(8):894; author reply 894. PubMed ID: 21960171
    [No Abstract]   [Full Text] [Related]  

  • 2. Like total ghrelin, acylated ghrelin is also lower in HD patients with cardiovascular disease.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Sparopoulou T; Stefanidis I; Galaktidou G
    Kidney Int; 2011 Oct; 80(7):783; author reply 783-4. PubMed ID: 21918561
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
    Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
    Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ghrelin a biomarker for mortality in end-stage renal disease?
    Mak RH; Cheung WW
    Kidney Int; 2011 Apr; 79(7):697-9. PubMed ID: 21403653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Beberashvili I; Katkov A; Sinuani I; Azar A; Shapiro G; Feldman L; Gorelik O; Stav K; Efrati S
    Am J Nephrol; 2018; 47(4):254-265. PubMed ID: 29694945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Association of leptin with mortality in patients on maintenance hemodialysis: a prospective study.
    Einollahi B; Taghipour M; Motalebi M
    Iran J Kidney Dis; 2014 Sep; 8(5):428-30. PubMed ID: 25194413
    [No Abstract]   [Full Text] [Related]  

  • 7. Leptin is a negative acute-phase protein in chronic hemodialysis patients.
    Mohkam M
    Iran J Kidney Dis; 2014 Jul; 8(4):263-4. PubMed ID: 25001131
    [No Abstract]   [Full Text] [Related]  

  • 8. Obestatin and ghrelin interplay in hemodialysis patients.
    Mafra D; Guebre-Egziabher F; Cleaud C; Arkouche W; Mialon A; Drai J; Fouque D
    Nutrition; 2010; 26(11-12):1100-4. PubMed ID: 20018486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke.
    Kawada T
    Int J Cardiol; 2016 Jan; 202():941. PubMed ID: 26427544
    [No Abstract]   [Full Text] [Related]  

  • 10. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients.
    Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH
    Ther Apher Dial; 2010 Dec; 14(6):552-9. PubMed ID: 21118362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients.
    Kalantar-Zadeh K; Fouque D; Kopple JD
    J Ren Nutr; 2004 Apr; 14(2):64-71. PubMed ID: 15060870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis in terms of reducing cardiovascular events.
    Eyuboglu M; Senarslan O
    Int J Cardiol; 2016 Jan; 202():97. PubMed ID: 26386932
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic inflammation in PD patients.
    Chung SH; Heimbürger O; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2003; (140):104-11. PubMed ID: 12800350
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease.
    Naufel MF; Bordon M; de Aquino TM; Ribeiro EB; de Abreu Carvalhaes JT
    Pediatr Nephrol; 2010 Dec; 25(12):2477-82. PubMed ID: 20734087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional Status Predicts 10-Year Mortality in Patients with End-Stage Renal Disease on Hemodialysis.
    Kang SS; Chang JW; Park Y
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
    Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis: Membrane flux, dialysate purity and cardiovascular outcomes.
    Grooteman M; Nubé M
    Nat Rev Nephrol; 2013 Aug; 9(8):439-41. PubMed ID: 23797202
    [No Abstract]   [Full Text] [Related]  

  • 18. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender difference of circulating ghrelin and leptin concentrations in chronic Helicobacter pylori infection.
    Chuang CH; Sheu BS; Yang HB; Lee SC; Kao AW; Cheng HC; Chang WL; Yao WJ
    Helicobacter; 2009 Feb; 14(1):54-60. PubMed ID: 19191897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nutritional status of chronic renal failure patients following the initiation of hemodialysis treatment.
    Lindsay R
    Am J Kidney Dis; 2002 Jul; 40(1):205-7. PubMed ID: 12087581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.